Peng DQ - Search Results

1

2023 Chinese guideline for lipid management.

Li JJ, Zhao SP, Zhao D, Lu GP, Peng DQ, Liu J, Chen ZY, Guo YL, Wu NQ, Yan SK, Wang ZW, Gao RL. Li JJ, et al. Among authors: peng dq. Front Pharmacol. 2023 Aug 29;14:1190934. doi: 10.3389/fphar.2023.1190934. eCollection 2023. Front Pharmacol. 2023. PMID: 37711173 Free PMC article. Review.

2

Elevated soluble CD40 ligand is related to the endothelial adhesion molecules in patients with acute coronary syndrome.

Peng DQ, Zhao SP, Li YF, Li J, Zhou HN. Peng DQ, et al. Clin Chim Acta. 2002 May 7;319(1):19-26. doi: 10.1016/s0009-8981(02)00014-1. Clin Chim Acta. 2002. PMID: 11922919

3

[Electrophoresis in the quantitative determination of cholesterol in lipoprotein fractions and its clinical application].

Xu ZM, Zhao SP, Peng DQ. Xu ZM, et al. Among authors: peng dq. Hunan Yi Ke Da Xue Xue Bao. 2002 Jun 28;27(3):250-2. Hunan Yi Ke Da Xue Xue Bao. 2002. PMID: 12575306 Chinese.

4

Gene-gene interaction of PPARgamma and ApoE affects coronary heart disease risk.

Peng DQ, Zhao SP, Nie S, Li J. Peng DQ, et al. Int J Cardiol. 2003 Dec;92(2-3):257-63. doi: 10.1016/s0167-5273(03)00101-3. Int J Cardiol. 2003. PMID: 14659862

5

Early effect of pravastatin on serum soluble CD40L, matrix metalloproteinase-9, and C-reactive protein in patients with acute myocardial infarction.

Li J, Zhao SP, Peng DQ, Xu ZM, Zhou HN. Li J, et al. Among authors: peng dq. Clin Chem. 2004 Sep;50(9):1696-9. doi: 10.1373/clinchem.2003.030940. Epub 2004 Jul 20. Clin Chem. 2004. PMID: 15265816 Clinical Trial. No abstract available.

6

[Serum soluble CD40L level and its application in coronary heart disease].

Li J, Peng DQ, Zhao SP. Li J, et al. Among authors: peng dq. Hunan Yi Ke Da Xue Xue Bao. 2003 Dec;28(6):611-4. Hunan Yi Ke Da Xue Xue Bao. 2003. PMID: 15804073 Chinese.

7

[Changes and relations of soluble plasma CD40L and matrix metalloproteinase-9 levels in patients with coronary heart disease].

Li J, Zhao SP, Peng DQ, Zhou HN. Li J, et al. Among authors: peng dq. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Oct;29(5):517-20. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004. PMID: 16137036 Chinese.

8

[Focusing on high density lipoprotein: from quantity to quality].

Peng DQ, Zhao SP. Peng DQ, et al. Zhonghua Yi Xue Za Zhi. 2007 Feb 6;87(6):363-5. Zhonghua Yi Xue Za Zhi. 2007. PMID: 17456373 Chinese. No abstract available.

9

Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.

Zhao SP, Peng DQ, Yu BL, Huo Y; CHILLAS investigators. Zhao SP, et al. Among authors: peng dq. Am Heart J. 2009 Oct;158(4):509-512.e1. doi: 10.1016/j.ahj.2009.07.030. Am Heart J. 2009. PMID: 19781407 Clinical Trial.

10

HDL and immunomodulation: an emerging role of HDL against atherosclerosis.

Yu BL, Wang SH, Peng DQ, Zhao SP. Yu BL, et al. Among authors: peng dq. Immunol Cell Biol. 2010 Mar-Apr;88(3):285-90. doi: 10.1038/icb.2009.112. Epub 2010 Jan 12. Immunol Cell Biol. 2010. PMID: 20065996 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters